Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-28 @ 12:19 PM
Study NCT ID:
NCT01113957
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2010-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-26
First Submit QC Date:
None
Study First Post Date:
2010-04-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-06-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-06-01
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL